The Current Ratio as of December 2025 (TTM) for AstraZeneca Pharma India Limited (ASTRAZEN.NS) is 1.87

According to AstraZeneca Pharma India Limited’s latest financial reports and current stock price. The company's current Current Ratio is 1.87. This represents a change of 98.03% compared to the average of 0.95 of the last 4 quarters.

AstraZeneca Pharma India Limited (ASTRAZEN.NS) Historical Current Ratio (quarterly & annually)

How has ASTRAZEN.NS Current Ratio performed in the past?

The mean historical Current Ratio of AstraZeneca Pharma India Limited over the last ten years is 1.80. The current 1.87 Current Ratio has changed 10.28% with respect to the historical average. Over the past ten years (40 quarters), ASTRAZEN.NS's Current Ratio was at its highest in in the March 2024 quarter at 2.61. The Current Ratio was at its lowest in in the December 2015 quarter at 0.

AstraZeneca Pharma India Limited (ASTRAZEN.NS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of AstraZeneca Pharma India Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AstraZeneca Pharma India Limited (ASTRAZEN.NS) Average Current Ratio

How has ASTRAZEN.NS Current Ratio performed in the past?

The current Current Ratio of AstraZeneca Pharma India Limited (ASTRAZEN.NS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

AstraZeneca Pharma India Limited (ASTRAZEN.NS) Current Ratio vs. Peers

How is ASTRAZEN.NS’s Current Ratio compared to its peers?

AstraZeneca Pharma India Limited’s Current Ratio is greater than Piramal Enterprises Limited (0), less than Neuland Laboratories Limited (1.96), less than Neuland Laboratories Limited (1.96), greater than Piramal Pharma Limited (1.43), less than J. B. Chemicals & Pharmaceuticals Limited (3.79), less than J. B. Chemicals & Pharmaceuticals Limited (3.79), greater than Eris Lifesciences Limited (0.91), greater than Eris Lifesciences Limited (0.91), greater than Wockhardt Limited (1.56), greater than Wockhardt Limited (1.56),

Build a custom stock screener for AstraZeneca Pharma India Limited (ASTRAZEN.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AstraZeneca Pharma India Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AstraZeneca Pharma India Limited (ASTRAZEN.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AstraZeneca Pharma India Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.